Moderna G&A decreased by 43.8% to $173M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.4%, from $212M to $173M. Over 4 years (FY 2021 to FY 2025), G&A shows an upward trend with a 15.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
A decrease relative to revenue indicates improved operational efficiency, while a significant increase may suggest bloated corporate overhead.
Detailed definition
General and administrative expenses cover the overhead costs required to run the business, including executive compensat...
Peer comparison
Standard operating expense category; investors look for G&A as a percentage of revenue to gauge administrative discipline.
Metric ID:
general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $121M | $168M | $201M | $268M | $211M | $278M | $375M | $305M | $332M | $442M | $470M | $274M | $268M | $281M | $351M | $212M | $230M | $268M | $308M | $173M |
| QoQ Change | — | +38.8% | +19.6% | +33.3% | -21.3% | +31.8% | +34.9% | -18.7% | +8.9% | +33.1% | +6.3% | -41.7% | -2.2% | +4.9% | +24.9% | -39.6% | +8.5% | +16.5% | +14.9% | -43.8% |
| YoY Change | — | — | — | — | +74.4% | +65.5% | +86.6% | +13.8% | +57.3% | +59.0% | +25.3% | -10.2% | -19.3% | -36.4% | -25.3% | -22.6% | -14.2% | -4.6% | -12.3% | -18.4% |
Range$121M – $470M
CAGR+7.8%
Avg YoY Growth+13.7%
Median YoY Growth-7.4%
G&A at Other Companies
Frequently Asked Questions
- What is Moderna's g&a?
- Moderna (MRNA) reported g&a of $173M in Q1 2026.
- How has Moderna's g&a changed year-over-year?
- Moderna's g&a decreased by 18.4% year-over-year, from $212M to $173M.
- What is the long-term trend for Moderna's g&a?
- Over 4 years (2021 to 2025), Moderna's g&a has grown at a 15.8% compound annual growth rate (CAGR), from $567M to $1.02B.
- What does g&a mean?
- The overhead costs associated with managing the day-to-day operations of the company.